Vascularization of repaired limb bone defects using chitosan-β-tricalcium phosphate composite as a tissue engineering
Le Yang1, Qinghua Wang2, Lihua Peng3
1Saint Petersburg State I.P. Pavlov Medical University, St. Petersburg 197101, Russia.
Molecular Medicine Reports
|April 23, 2015
Summary
Chitosan-β-tricalcium phosphate composite is a viable option for bone tissue engineering. This injectable material, combined with mesenchymal stem cells (MSCs), effectively promotes osteogenesis and vascularization in bone defect repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Research
Background:
- Histocompatibility is crucial for successful bone tissue engineering.
- Chitosan-β-tricalcium phosphate composites offer potential for bone defect repair.
Purpose of the Study:
- To assess the feasibility of a chitosan-β-tricalcium phosphate composite for repairing limb bone defects.
- To evaluate the therapeutic effects of this composite on osteogenesis and vascularization.
Main Methods:
- Beagle mesenchymal stem cells (MSCs) were cultured with the composite.
- An in vivo study involved implanting scaffolds with or without MSCs into beagle femur defects.
- Scanning electron microscopy and MTT assays were used for analysis.
Main Results:
- The chitosan-β-tricalcium phosphate composite demonstrated compatibility with MSCs.
- MSCs cultured with the composite showed similar growth and proliferation rates compared to the control group.
- Combined implantation of MSCs and scaffolds significantly promoted osteogenesis and vascularization in bone defects.
Conclusions:
- The chitosan-β-tricalcium phosphate composite is a safe and effective injectable material for bone tissue engineering.
- Simultaneous delivery of stem cells with the composite carrier enhances bone defect repair efficacy.
